✦ LIBER ✦

Single-Drug Chemotherapy of Canine Transmissible Venereal Tumor With Cyclophosphamide, Methotrexate, or Vincristine

✍ Scribed by E. I. Amber; R. A. Henderson; J. B. Adeyanju; E. O. Gyang

Book ID: 114951546
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 422 KB
Volume: 4
Category: Article
ISSN: 0891-6640
DOI: 10.1111/j.1939-1676.1990.tb00887.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seasonality of side effects during chemo

Seasonality of side effects during chemotherapy of canine transmissible venereal tumor with vincristine

✍ Karime C. Scarpelli; Maria Luiza C.R. Valladão; Edson M. Scarpelli; Konradin Met 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Treatment of bronchogenic carcinoma with

Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine

✍ Pierre Alberto; Kurt W. Brunner; Georg Martz; Jean-Paul Obrecht; Roland W. Sonnt 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Intraarterial hepatic chemotherapy with

Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats

✍ S. Kurth; D. Bulian; B. Kreft; Th. Riemenschneider 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 37 KB

Adjuvant chemotherapy with cyclophospham

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes : 20-year results of a Southwest Oncology Group Study

✍ Saul E. Rivkin; Stephanie J. Green; Danika Lew; John J. Costanzi; John W. Athens 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND Adjuvant combination chemotherapy with cyclophosphamide, methotrexate, and 5‐fluorouracil plus vincristine and prednisone (CMFVP) was compared with single‐agent L‐phenylalanine mustard (L‐PAM) for the treatment of patients with axillary lymph node positive primary breast